Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited
Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited
Source: goodwinlaw.com